Clinical Trials Directory

Trials / Unknown

UnknownNCT04726943

RF Applications for Residual LAA Leaks

Radiofrequency Energy Applications Targeting Significant Residual Leaks After Left Atrial Appendage Occlusion

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Texas Cardiac Arrhythmia Research Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Although the clinical impact of residual left atrial appendage (LAA) leaks still requires confirmation, its patency resulting from incomplete LAA closure may promote blood stagnation and thrombus formation, and increase the risk of thromboembolic events. The main purpose of this trial is to evaluate the safety and efficacy of percutaneous leak closure with radiofrequency energy applications.

Detailed description

Therapies locally targeting the LAA via occlusion, exclusion, or excision have emerged as an alternative and effective approach for stroke prophylaxis in AF patients, especially those with OAC contra-indications. Despite mounting evidence of their safety and efficacy in comparison with standard oral therapy, device-related thrombus and incomplete LAA closure resulting in residual, significant leak may occur, potentially hindering an effective stroke prevention. Radiofrequency energy has been adopted in several settings (e.g., vascular, orthopedic, aesthetic surgery) to achieve thermal-induced tissue retraction.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency Energy ApplicationsRF energy applications to the atrial edge of a leak resulting from incomplete LAA occlusion

Timeline

Start date
2021-02-01
Primary completion
2022-02-01
Completion
2022-12-31
First posted
2021-01-27
Last updated
2021-02-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04726943. Inclusion in this directory is not an endorsement.

RF Applications for Residual LAA Leaks (NCT04726943) · Clinical Trials Directory